Search results
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 16 hours agoA health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
GuruFocus.com via Yahoo Finance· 5 hours agoIn response, Novavax is implementing cost reduction strategies aimed at significantly decreasing R&D and SG&A expenses in 2025 to below $500 million. Furthermore, the company ...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with
Guru Focus· 5 hours agoOn May 10, 2024, Novavax Inc (NVAX, Financial) disclosed its financial results for the first quarter ended March 31, 2024, through an 8-K filing. The company, a prominent ...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
WKRN Nashville· 16 hours agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing ...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
WFRV 5 Green Bay· 16 hours agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, has entered into a co-exclusive licensing agreement with Sanofi ...
Novavax erases doubts about its ability to remain in business
Reuters via AOL· 16 hours agoIn February, Novavax had raised doubts about its ability to remain in business and announced plans...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 4 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
AstraZeneca withdraws Covid-19 jab from the market
PA Media: Science via Yahoo News· 2 days ago“The key reason for the withdrawal is likely to be that other Covid vaccines, such as Pfizer and Moderna, are essentially better products. AstraZeneca is...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 1 week agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
"FLiRT" COVID variants are now more than a third of U.S. cases. Scientists share what we know about...
CBS News· 8 hours agoMore than a third of COVID-19 cases in the U.S. are now estimated to be from a new, fast-growing...